Here’s Why Baron Funds Remains Optimistic in Zoetis (ZTS)
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,326,448 | $627,335 | +172% | 0.78% |
| 2. | Cantillon Capital Management William Von Mueffling | 1,878,890 | $354,340 | +3% | 2.53% |
| 3. | Ako Capital Nicolai Tangen | 1,738,652 | $327,892 | -3% | 3.53% |
| 4. | Intermede Investment Partners Barry Dargan | 1,059,124 | $199,740 | +8% | 4.67% |
| 5. | Renaissance Technologies Jim Simons | 922,274 | $173,932 | +360% | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | Director | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | Director | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | Director | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | Director | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | Director | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $175.00 | 4,334 | Officer | 23,687 | 2022-06-27 | Filing | |
| $162.31 | 1,855 | Director | 6,782 | 2022-06-10 | Filing | |
| $178.96 | 2,167 | Officer | 23,687 | 2022-04-26 | Filing | |
| $188.15 | 6,000 | Officer | 8,218 | 2022-03-16 | Filing | |
| $192.59 | 5,600 | Officer, Director | 39,743 | 2022-02-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,384,431 | $449,679,841 | 0.19% | |
| 2. | 251,181 | $47,370,225 | 0.28% | |
| 3. | 230,708 | $43,509,222 | 0.05% | |
| 4. | 64,337 | $12,133,315 | 0.15% | |
| 5. | 41,766,559 | $7,876,755 | 0.21% |
News See All
9 Dividend Stocks to Buy According to Richard Hamm’s Bristol Gate Capital
In this article, we discuss 9 dividend stocks to buy according to Richard Hamm's Bristol Gate Capital.
5 Best Recession Stocks to Buy According to Jim Cramer
In this article, we discuss the 5 best recession stocks to buy according to Jim Cramer.
10 Stocks You Should Sell According to Motley Fool
In this article, we discuss 10 stocks you should sell according to Motley Fool.
10 Biotech Stocks Hedge Funds Are Talking About
In this article, we present the list of the 10 biotech stocks hedge funds are talking about.
5 Stocks to Buy According to Peter Simmie’s Bristol Gate Capital
In this article, we discuss 5 stocks to buy according to Peter Simmie's Bristol Gate Capital.
Were Hedge Funds Right About Zoetis Inc (ZTS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Zoetis Inc (ZTS) Fell Out Of Favor With Hedge Funds?
Is Zoetis Inc (NYSE:ZTS) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ...
Nicolai Tangen’s AKO Capital Is Investing In These 10 Stocks
In this article, we discuss 10 stocks Nicolai Tangen's AKO Capital is investing in.
Polen Capital on Zoetis (ZTS): “We Maintain High Conviction in the Company”
Polen Capital, an investment management firm, published its “Polen Global Growth” third quarter 2021 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
